Rhizen Pharma gets USFDA approval for Phase I trials of COVID-19 drug
The initial study would evaluate single ascending doses of the RP7214 in healthy volunteers and that dosing is expected to…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.